-
The EASD president speaks about the hot topics of this year's congress, new e-learning opportunities, and the measures taken by EASD to support its members in times of COVID-19
-
Flash glucose monitoring can expand the timeframe in which glucose level is in the range of 70-180 mg/dl, compared to blood glucose self-monitoring, and therefore shortening hypoglycemia phases.
-
Pulmonary fibrosis can occur secondarily after infection, especially in patients who suffered from severely impaired diffusion capacity during the acute infection.
-
Older people today have better functional abilities compared with those 30 years ago. Physical and cognitive performance of the 75-80-year-old group was juxtaposed with that of the 1990s.
-
Singing is as effective as classical pulmonary rehabilitation in COPD patients as a means of improving physical performance.
-
Physical activity should play a key role in multi-component interventions of sleep apnea patients as it has a positive influence on the Apnea-Hypopnea Index and risk factors for diseases such as diabetes.
-
An increasing variety of nicotine-containing products is available. The consumption of e-cigarettes, traditional cigarettes, and also cannabis, could be more harmful than smoking alone.
-
Results from a large pooled cohort study show that even less than 10 cigarettes a day significantly increases the risk of lung cancer or respiratory disease death.
-
Nasal high-flow therapy and non-invasive ventilation performed equally well in people with cCOPD with hypercapnia. NHF could therefore be a valuable addition to existing oxygen delivery devices.
-
People infected with COVID-19 often suffer long-term lung function impairment, but preliminary CovILD study results found improvement over time for many patients.
-
Objective markers for asthma-like coughs can be measured via a smartphone. This technology could solve the current problems in monitoring respiratory diseases.
-
An analysis of longitudinal data found an association between lung function and cognitive impairment in older people over an average 12-years follow-up period.
-
The annual ESC congress recorded four new or updated guidelines. We report some key points related to the management of non-ST segment elevation acute coronary syndromes.
-
The current hype around SGLT2 inhibitors in the treatment of heart failure patients is more than justified, according to Prof. Martin Cowie
-
An educational program for patients with atrial fibrillation and their healthcare providers did not result in more oral anticoagulants being administered after one year than with the usual treatment
-
Patients under successful PCI for angina pectoris and acute coronary syndrome without ST elevation have good long-term results with optimal medical therapy. In the ATPCI study, the routine use of trimetazidine did not lead to a reduction in cardiac events in this patient group.
-
Restrictive blood transfusion has no negative impact on clinical outcomes compared to more liberal strategies in anemic patients with acute MI. Restrictive strategies resulted in fewer infections and acute lung injuries.
-
An evaluation of COVID-19 patients admitted to a Wuhan hospital shows that they were at high risk of thromboembolic events and bleeding, as well as an increased risk of mortality.
-
Modern antidiabetics, such as SGLT2 inhibitors, have shown positive effects on cardiovascular risks or kidney function for diabetics. However, recent study results show an equal benefit for heart failure patients regardless of their diabetes status.
-
Prof. Casadei talks about what the cardiology field has learnt from the COVID-19 crisis, what positive aspects have emerged from it, and how to turn the profession back into a vocation.
